30
Participants
Start Date
July 25, 2024
Primary Completion Date
July 22, 2026
Study Completion Date
January 22, 2027
Riociguat (Adempas)
Oral riociguat administered according to established dose-adjustment scheme. Riociguat will be administered starting at at 1mg three times per day. If patient systolic blood pressure maintains at 95mmHg or higher, the dose will be increased 0.5mg every 2 weeks up to a maximum dose 2.5mg three times per day over 8-week period
RECRUITING
Prince of Wales Hospital, Hong Kong
Chinese University of Hong Kong
OTHER